HOME >> MEDICINE >> NEWS
Drug reverses bone loss in men with prostate cancer during the first year of treatment

e and can recover bone density that already has been lost," Ryan said.

Researchers also found a positive effect of zoledronic acid on bone markers, measurements of bone loss that are found in blood and urine. This study supports current guidelines that recommend monitoring bone density of men on hormone therapy and initiating bisphosphonate treatment if the bone density falls.

Prostate cancer is the most common cancer in men and the second leading cause of cancer-related death in American men. Overall, 1 in 6 men will develop prostate cancer during his lifetime.


'"/>

Contact: Rachel MacKnight
macknigh@ohsu.edu
503 494-8231
Oregon Health & Science University
25-Feb-2006


Page: 1 2

Related medicine news :

1. Scripps research team reverses Friedreichs ataxia defect in cell culture
2. Exercise reverses unhealthy effects of inactivity
3. Dynamic duo: Combination therapy reverses type 1 diabetes
4. Repetition reverses med students stethoscope shortcomings
5. New drug reverses effects of sleep deprivation on brain
6. Heart valve ring reverses damage from congestive heart failure, easing symptoms
7. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
8. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
9. African-American men understimate risk of prostate cancer
10. Treatment for early prostate cancer associated with type of specialist seen
11. Nonhormonal drug reduces hot flashes in men treated for prostate cancer

Post Your Comments:
(Date:8/31/2015)... TN (PRWEB) , ... August 31, 2015 , ... ... urgent care and accessible primary care, is enhancing its existing presence in Tennessee ... in Knoxville. The location is the company’s second in Knoxville, sixteenth in Tennessee, ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a ... their competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the ... of Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking ...
(Date:8/31/2015)... ... 31, 2015 , ... In preparation for this November’s National Family Caregivers Month, ... sound amplifier, is offering caregivers “7 Reasons to Care about Hearing Health.” The information ... a variety of home healthcare challenges, specifically as they relate to caring for the ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... association for physicians and allied health professionals dedicated to using lifestyle as ... today the establishment of the Lifestyle Medicine Lifetime Achievement and Trailblazer Awards, ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... nation’s leading nonprofit authority on the use of health IT to create efficiencies ... fall conference, WEDI-Con 2015 . Taking place at the Hyatt Regency Reston ...
Breaking Medicine News(10 mins):Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3
(Date:8/31/2015)... 31, 2015  Qualcomm Incorporated (NASDAQ: QCOM ... Life, Inc., is collaborating with Davita Healthcare ... solutions powered by Qualcomm Life,s 2net™ Device Connectivity ... continuous care, informed interventions and better management of ... Life,s annual Connect 2015 ecosystem conference ...
(Date:8/31/2015)... WOODCLIFF LAKE, N.J. and STAMFORD, ... the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., and ... into a worldwide collaboration agreement for the development and ... a dual orexin receptor antagonist entering Phase III clinical ... Under the terms of the agreement, Eisai and Purdue ...
(Date:8/30/2015)... , August 31, 2015 ... healthbank to deliver ... the world,s first citizen-owned health data transaction platform, announced ... Netcetera to engineer and bring to market ... (Logo: http://photos.prnewswire.com/prnh/20150828/261966) , "Our business model is ...
Breaking Medicine Technology:Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4
Cached News: